Duramed gets FDA OK on Seasonique

Duramed Pharmaceuticals has received FDA approval for Seasonique, an extended cycle contraceptive that should hit the markets in July. Seasonique's low-dose estrogen pills--which limit menstrual cycles to four times a year--replace a series of placebos in the monthly cycle that researchers say will help limit bloating and hormonal fluctuations.

- read the report from the Kaiser Network

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.